Internal Medicine Alert – December 30, 2012
December 30, 2012
View Issues
-
Is Insomnia a Disease or a Symptom?
In this small pilot study of patients who sought help for insomnia, most of the awakenings were actually caused by sleep-disordered breathing. -
Is the Statin Making the Patient Tired?
A randomized, controlled trial showed that moderate doses of simvastatin or pravastatin resulted in reduced energy or exertional fatigue in up to 40% of patients, especially in women. -
Patients Should Take a Break from Being Sedentary
Sedentary time is associated with an increased risk of diabetes, cardiovascular disease, and cardiovascular and all-cause mortality. -
Boning Up on What is New with Calcium
This study does not support the hypothesis that high calcium intake increases coronary artery calcification -
Pharmacology Update: Tofacitinib Tablets (Xeljanz®)
The FDA has approved a new drug with a novel mechanism of action for the treatment of rheumatoid arthritis in patients intolerant to or who have had inadequate response to methotrexate. Tofacifinib is an oral Janus kinase (JAK) inhibitor and is marketed by Pfizer as Xeljanz. -
Clinical Briefs By Louis Kuritzky, MD
Zoledronic Acid Treatment of Osteoporosis in Men; Relapsing Lyme Disease: Fact or Fiction?; Hypertension and Gout